We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Synthetic PCR Mimic Could Lead to Highly Sensitive Medical, Environmental Diagnostics

By LabMedica International staff writers
Posted on 25 Oct 2010
Scientists have taken another leap towards realizing a new class of polymerase chain reaction (PCR) enzyme mimics, creating a path for the development of highly sensitive chemical detection technology that goes beyond nucleic acid targets.

The blueprint for constructing synthetic structures to detect and signal the presence of targets such as small molecule medical analytes (signalers of disease or bodily malfunction, such as neurotransmitters) and environmental hazards is inspired by biology and its allosteric enzymes. More...
The technique also could be helpful in catalysis and the production of polymers, including plastics.

The research, which has the potential for higher sensitivity than that of current detection applications, was published October 1, 2010 by the journal Science. "PCR--the backbone of the biodiagnostics industry--is an enzyme that binds to a nucleic acid and changes shape, turning on a catalyst that makes copies of the nucleic acid for detection purposes,” said Chad A. Mirkin, a professor of chemistry in the Weinberg College of Arts and Sciences at Northwestern University (Evanston, IL, USA). "What if you could do that for thousands of small molecules of interest?” he said. "We'd like to be able to detect tiny amounts of targets important to medicine and the environment, opening avenues to new types of diagnostic tools, just as PCR did for the modern fields of medical diagnostics and forensics. Our new catalysts could make that possible.”

Dr. Mirkin led a team of chemists who built a synthetic structure that sandwiches the catalyst between two chemically inert layers. This triple-layer architecture allows the use of any catalyst, as it will be kept inactive, or in an "off” state, until triggered by a specific small molecule.

The enzyme mimic behaves similar to allosteric enzymes found in nature, catalysts that change shape to perform their functions. When the mimic reacts with a specific small molecule, the triple-layer structure changes shape and opens, exposing the catalyst. The resulting catalytic reaction signals the presence of the small molecule target, similar to the way PCR amplifies a single piece of DNA.

"One of our challenges as synthetic chemists has been learning to synthesize structures inspired by biology but that have nothing to do with biology other than the fact we'd like such complex functions realized in man-made systems,” said Dr. Mirkin, also director of Northwestern's International Institute for Nanotechnology.

In the study reported in Science, the researchers use an aluminum salen complex as the catalyst in the three-layer structure. The addition of chloride (the reduced form of chlorine) triggers the catalyst and starts the polymerization process. (Chloride ion binds at an allosteric binding site, distant from the active or catalytic site.) The addition of an agent that removes the chloride stops the process, but the chloride can be added back to start it again.

Related Links:

Northwestern University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Urine Analyzer
respons® UDS100
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.